AT7867, soluble in DMSO and ethanol and insoluble in water, inhibits the phosphorylation of Akt with anti-inflammatory properties. It targets Akt1, PKA, Akt2, Akt3, c-Src, CDK2, Chk1, EGFR, FGFR3, GSK-3β, and MEK1.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.